|Dr. Carl I. Schwartz||CEO, Director & Member of Medical Advisory Board||N/A||N/A||1941|
|Mr. Robert L. Myers||CFO & Sec.||164.23k||N/A||1955|
|Mr. David Orrin Johnson||Chief Operating Officer||185.05k||N/A||1953|
|Mr. Kevin Hungerford||VP of Sales & Marketing||N/A||N/A||N/A|
|Mr. David Dauwalter||Director of Product Management||N/A||N/A||N/A|
Precision Therapeutics Inc. manufactures environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the United States. It also engages in the development of a healthcare contract research organization (CRO) that provides personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. The company's CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. It offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. The company's system replaces the manual process of collecting fluids in canisters, and transporting and dumping in sinks outside of the operating room. It markets and sells its products through in-house sales force and independent distributors to hospitals, surgical centers, and other medical facilities, where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. is based in Eagan, Minnesota.
Precision Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.